Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Aspira Women's Health Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 2
- −23 vs. Q1 2025
- Shares held
- 110.6K
- −753.6K (−87.2%) vs. Q1 2025
- Total value
- $15.7K
- −$65.3K (−80.6%) vs. Q1 2025
- New holders
- 0
- 1 more added
- Sold out
- 23
- 1 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AWHL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $392 |
| Q2 2025 | 2 | $15.7K |
| Q1 2025 | 25 | $81.0K |
| Q4 2024 | 26 | $1.03M |
| Q3 2024 | 25 | $1.91M |
| Q2 2024 | 26 | $2.08M |
| Q1 2024 | 23 | $6.15M |
| Q4 2023 | 24 | $2.92M |
| Q3 2023 | 24 | $3.53M |
| Q2 2023 | 22 | $1.75M |
| Q1 2023 | 45 | $3.25M |
| Q4 2022 | 47 | $3.24M |
| Q3 2022 | 58 | $4.46M |
| Q2 2022 | 72 | $7.02M |
| Q1 2022 | 92 | $22.9M |
| Q4 2021 | 98 | $50.9M |
| Q3 2021 | 92 | $97.0M |
| Q2 2021 | 95 | $174.1M |
| Q1 2021 | 97 | $211.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Aspira Women's Health Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 67,484 | $9.45K | 0.00% | +64,834+2,446.6% | Added |
| XTX Topco Ltd | 43,090 | $6.29K | 0.00% | −19,094−30.7% | Reduced |
| HRT Financial LP | 0 | $0 | 0.00% | −182,286−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −131,968−100.0% | Sold out |
| BlackRock, Inc. | 0 | $0 | 0.00% | −82,232−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −79,183−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −63,528−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −52,851−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −34,196−100.0% | Sold out |
| Pine Valley Investments Ltd Liability Co | 0 | $0 | 0.00% | −33,400−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −29,808−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −23,436−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −19,749−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −16,799−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −14,999−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −4,130−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,061−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,694−100.0% | Sold out |
| Operose Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −610−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −119−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −100−100.0% | Sold out |